Ayrton of Ghana Reaches 10-Week High on Strategic Investor Stake

Ayrton Drug Manufacturing Ltd. (AYRTN), a manufacturer of pharmaceutical products in Ghana, rose to the highest since Feb. 3 on speculation a “strategic investor” acquired a stake in the company.

The stock gained 1 pesewa, or 6.3 percent, to close at 17 pesewas as of 2:40 p.m. in the capita, Accra.

“A strategic investor was taking a position in the company,” Hilary Lomotey, a trader with Renaissance Capital said in a telephone interview from Accra, declining to give details. “The person has an interest in a pharmaceuticals company and Ayrton Drug is the biggest in terms of market capitalization on Ghana’s market.”

To contact the editor responsible for this story: Antony Sguazzin at asguazzin@bloomberg.net.

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.